These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20024863)

  • 1. [Use of eptifibatide in patients with acute stent thrombosis, requiring urgent surgical revascularisation - report of 2 cases].
    Wilczyński M; Bochenek T; Góral J; Knast K; Abu Samra R; Wita K; Bochenek A
    Kardiol Pol; 2009 Nov; 67(11):1313-6. PubMed ID: 20024863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early versus delayed, provisional eptifibatide in acute coronary syndromes.
    Giugliano RP; White JA; Bode C; Armstrong PW; Montalescot G; Lewis BS; van 't Hof A; Berdan LG; Lee KL; Strony JT; Hildemann S; Veltri E; Van de Werf F; Braunwald E; Harrington RA; Califf RM; Newby LK;
    N Engl J Med; 2009 May; 360(21):2176-90. PubMed ID: 19332455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary delivery of eptifibatide with the ClearWay® RX infusion catheter.
    Deibele AJ; Michael Gibson C
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):222-7. PubMed ID: 20824759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.
    Milicic D; Skoric B; Lovric D
    J Invasive Cardiol; 2009 Aug; 21(8):E157-60. PubMed ID: 19652267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous subacute stent thrombosis of two drug-eluting stents in the left anterior descending and the circumflex coronary arteries. Case report and review of the literature.
    Movahed MR; Vu J; Ahsan C
    J Invasive Cardiol; 2006 Jul; 18(7):E198-202. PubMed ID: 16816448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study.
    Kaul U; Gupta RK; Haridas KK; Ramesh SS; Sethi KK; Singh B; Agarwal R; Yadave RD; Ghose T; Sapra RR; Bajaj R; Shahi M; Bhagwat A; Kumar P; Mathews OP; Soni PK;
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):497-503. PubMed ID: 12455085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prehospital therapy with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide in patients with suspected acute coronary syndromes: the Bochum feasibility study.
    Hanefeld C; Sirtl C; Spiecker M; Bojara W; Grewe PH; Lawo T; Mügge A
    Chest; 2004 Sep; 126(3):935-41. PubMed ID: 15364776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial.
    Deibele AJ; Jennings LK; Tcheng JE; Neva C; Earhart AD; Gibson CM
    Circulation; 2010 Feb; 121(6):784-91. PubMed ID: 20124127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation.
    Chitkara K; Hogrefe K; Vasa-Nicotera M; Swanson N; Gershlick AH
    J Invasive Cardiol; 2006 Sep; 18(9):417-22. PubMed ID: 16954580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature.
    Pickett AM; Taylor DA; Ackman ML
    Pharmacotherapy; 2010 Apr; 30(4):127e-33e. PubMed ID: 20334463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.
    Urban P; Abizaid A; Banning A; Bartorelli AL; Baux AC; Džavík V; Ellis S; Gao R; Holmes D; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Spaulding C; Worthley S;
    J Am Coll Cardiol; 2011 Mar; 57(13):1445-54. PubMed ID: 21435513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late thrombosis of sirolimus-eluting stents following noncardiac surgery.
    Nasser M; Kapeliovich M; Markiewicz W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):516-9. PubMed ID: 15926177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.
    Gibson CM; Kirtane AJ; Murphy SA; Rohrbeck S; Menon V; Lins J; Kazziha S; Rokos I; Shammas NW; Palabrica TM; Fish P; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):668-75. PubMed ID: 16996831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent.
    Lee CH; Lim J; Low A; Tan HC; Lim YT
    Heart; 2006 Apr; 92(4):551-3. PubMed ID: 16537782
    [No Abstract]   [Full Text] [Related]  

  • 17. Cocaine-induced coronary thrombosis: what is the optimal treatment strategy.
    Rusovici A; Varkey S; Saeed Q; Klapholz M; Haider B; Kaluski E
    Cardiovasc Revasc Med; 2011; 12(2):133.e1-6. PubMed ID: 21421194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass.
    Dyke CM; Jennings LK; Maier G; Andreou C; Daly R; Tamberella MR
    J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):54-60. PubMed ID: 17495258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of thrombus burden with eptifibatide in a patient with a non-ST segment elevation acute coronary syndrome.
    Isaac JC; Levine GN
    J Invasive Cardiol; 2000 Dec; 12 Suppl D():21D-2D. PubMed ID: 11156719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.